State Key Laboratory of Microbial Technology, Shandong University, No. 72 Binhai Road, Qingdao, 266237, People's Republic of China.
Microb Cell Fact. 2019 Jan 31;18(1):22. doi: 10.1186/s12934-019-1075-3.
Lactococcus lactis is one of the most extensively characterized lactic acid bacteria, from physiological traits to industrial exploitation. Since last decade, L. lactis has been developed into cell factories for the production of bioactive compounds such as enzymes, vaccine antigens and natural products. However, its precise and efficient genome editing tools is still required to make L. lactis more suitable candidate for engineered functionality.
A high active recombinase, RecT of Enterococcus faecalis ATCC14506, was selected from six candidates and mediated homologous recombination between single-stranded DNA (ssDNA) and the L. lactis chromosomal rpoB locus with an efficiency of 100% after rifampin selection. To screen mutants without an externally selectable phenotype, the CRISPR/Cas9 system was used for counterselection, yielding an upp mutant with an efficiency of 46%. By optimization of the copy number of plasmid carrying the CRISPR/Cas9 system and the length of spacer sequence, the off-target efficiency of the recA, galK, hemN and noxD genes were eliminated. The ability of this optimized tool to perform sequential point mutation was demonstrated using the upp and galK gene loci as targets with improved efficiencies > 75%. Moreover, seamless genomic DNA deletions (50/100 bp) or insertion (a loxP site, 34 bp) was efficiently accomplished within 72 h.
The work provided a rapid, versatile and precise tool for L. lactis genomic engineering by combination of ssDNA recombineering with improved CRISPR/Cas9 counterselection. This tool will simplify the production of isogenic strains for assessment of gene function or construction of biosynthetic host.
乳球菌是研究最为广泛的乳酸细菌之一,涵盖了生理学特性到工业开发等多个方面。自上十年以来,乳球菌已被开发成生产生物活性化合物(如酶、疫苗抗原和天然产物)的细胞工厂。然而,为了使乳球菌更适合工程功能,仍需要精确且高效的基因组编辑工具。
从六个候选物中选择了一种高效的重组酶,即粪肠球菌 ATCC14506 的 RecT,它可以介导单链 DNA(ssDNA)与乳球菌染色体 rpoB 基因座之间的同源重组,经利福平筛选后效率达到 100%。为了筛选没有外部选择表型的突变体,使用 CRISPR/Cas9 系统进行反选择,得到一个 upp 突变体,效率为 46%。通过优化携带 CRISPR/Cas9 系统的质粒拷贝数和间隔序列的长度,消除了 recA、galK、hemN 和 noxD 基因的脱靶效率。该优化工具在以 upp 和 galK 基因为靶标的连续点突变中的应用证明了其效率>75%。此外,在 72 小时内可有效地完成无缝基因组 DNA 缺失(50/100 bp)或插入(loxP 位点,34 bp)。
通过 ssDNA 重组酶与改进的 CRISPR/Cas9 反选择相结合,这项工作为乳球菌基因组工程提供了一种快速、通用和精确的工具。该工具将简化同基因株的生产,用于评估基因功能或构建生物合成宿主。